Drug recall · April 10, 2013
CLONAZEPAM ORALLY DISINTERGRATING Tablets recall
Why: Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
- Lots / codes
Lot # 32900136A, Exp. 05/14
- Quantity
- 3 boxes
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- NC
- Initiated
- February 7, 2013 · Voluntary: Firm initiated
- Classified
- April 1, 2013
- Reported
- April 10, 2013
- Ended
- January 15, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.